Use of emollients in atopic dermatitis

• Published in: Journal of the European Academy of Dermatology and Venereology 2015-05, Vol.29 (5), p.854-857
• Main Authors: Ng, J.P.X., Liew, H.M., Ang, S.B.
• Format: Article
• Language: English
• Subjects: Dermatitis, Atopic - drug therapy; Dermatitis, Atopic - physiopathology; Emollients - administration & dosage; Humans; Steroids - therapeutic use; Water Loss, Insensible
• ISSN: 0926-9959; 1468-3083
• DOI: 10.1111/jdv.12864

Atopic dermatitis (AD) is a common inflammatory skin disorder that has strong financial and psychosocial impacts. Its pathogenesis is related to increased transepidermal water loss due to a defective skin epidermal barrier. Emollients serve as first‐line therapy during both acute flares and remission. However, their use is poorly characterized, posing therapeutic challenges to clinicians and patients. In this article, we review available evidence to provide recommendations, aiming to standardize and optimize the use of emollients in AD. Literature search was performed using Pubmed and Google. All articles were retrieved using Pubmed. Recommendations were graded based on the British Medical Journal's Grading of Recommendations Assessment, Development and Evaluation system and the American Academy of Family Physicians' Strength of Recommendation Taxonomy. Emollients should be applied post‐bathing. However, the need for immediate application is debatable. The optimal frequency for application is still undetermined, but multiple applications daily are encouraged. Ideally, a balance should be achieved between patient's compliance and clinical efficacy. Emollients hold the potential to act as steroid‐sparing agents, but more well‐designed studies are pertinent for a definite conclusion. At present, it is recommended that 250–500 g of emollients be applied every week. Finally, primary prevention of AD by regular application of emollients in high‐risk infants cannot yet be recommended.